Report Code: A03623 | Pages: NA | Mar 2023 | 6573 Views | ||
Author(s) : NA | Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Vagus Nerve Stimulation Market
Request Now !Vagus nerve stimulation (VNS) therapy is designed to avoid seizures by sending consistent, mild pulses of electrical signals to the brain through the vagus nerve. These pulses are delivered by a device, which resembles a pacemaker. Vagus nerve is a part of the autonomic nervous system that controls involuntary functions of the body such as heart rate. It passes through the neck, which passes between the chest and abdomen to the lower part of the brain. VNS device is referred to as the "pacemaker of the brain," and is placed under the skin on the chest wall. A wire runs from it to the vagus nerve in the neck. Vagus nerve stimulators are used in treatment of intractable epilepsy and treatment-resistant depression.
The major factors that drive the growth of global vagus nerve stimulation market are increase in prevalence of neurological disorders as migraine and epilepsy among all age groups and positive clinical outcomes regarding the use of this technique. However, dearth of skilled professionals and high cost associated with neurostimulator devices restrict the market growth. Conversely, increase in R&D activities to expand the indications for the use of neurostimulators is expected to provide lucrative growth opportunities to the market. For instance, vagus nerve stimulation is being explored for managing diseases related to organs and muscle function connected to the vagus nerve.
The report global vagus nerve stimulation market is segmented based on product, application, end user, biomaterial, and geography. On the basis of product, the market is bifurcated as implantable VNS devices and external VNS devices. By application, it is categorized into depression, epilepsy, and migraine. In terms of biomaterial, it is divided into ceramics, metallic, and polymerics. In terms of end user, it is classified into hospitals, ambulatory surgical centers (ASCS), and others. Regionally, the market is analyzed in North America, Europe, Asia-Pacific, and LAMEA.
The key players operating in the market include Medtronic Plc., ElectroCore LLC, LivaNova Plc., Boston Scientific Corporation, Aleva Neurotherapeutics SA, BioControl Medical, Bioness Inc., EnteroMedics Inc., Nevro Corporation, and NeuroPace Inc.
Key Benefits
Vagus Nerve Stimulation Market Report Highlights
Aspects | Details |
---|---|
By Product |
|
By Application |
|
By Biomaterial |
|
By End User |
|
By Region |
|
Key Market Players | Medtronic Plc., ElectroCore LLC, LivaNova Plc., Boston Scientific Corporation, Aleva Neurotherapeutics SA, BioControl Medical, Bioness Inc., EnteroMedics Inc., Nevro Corporation, NeuroPace Inc. |
Loading Table Of Content...
Start reading.
This Report and over 19,603+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers